2-(2,6-Dioxopiperidin-3-yl)-5-(7-hydroxyhept-1-yn-1-yl)isoindoline-1,3-dione

Catalog No. :
ACAVFX797
CAS No. :
2493430-94-5
Molecular Formula :
C20H20N2O5
Molecular Weight :
368.39

IUPAC Name:2-(2,6-dioxopiperidin-3-yl)-5-(7-hydroxyhept-1-yn-1-yl)isoindoline-1,3-dione

2-(2,6-Dioxopiperidin-3-yl)-5-(7-hydroxyhept-1-yn-1-yl)isoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2,6-Dioxopiperidin-3-yl)-5-(7-hydroxyhept-1-yn-1-yl)isoindoline-1,3-dione
IUPAC Name2-(2,6-dioxopiperidin-3-yl)-5-(7-hydroxyhept-1-yn-1-yl)isoindoline-1,3-dione
Molecular FormulaC20H20N2O5
Molecular Weight368.39
SMILESO=C1NC(C(CC1)N2C(C3=CC=C(C=C3C2=O)C#CCCCCCO)=O)=O
InChI KeyDPWAPUGVQFQSNT-UHFFFAOYSA-N
Synonym1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-(7-hydroxy-1-heptyn-1-yl)-;2-(2,6-dioxo-3-piperidyl)-5-(7-hydroxyhept-1-ynyl)isoindoline-1,3-dione;2-(2,6-Dioxo-3-piperidinyl)-5-(7-hydroxy-1-heptyn-1-yl)-1H-isoindole-1,3(2H)-dione (ACI);2-(2,6-dioxopiperidin-3-yl)-5-(6-hydroxyprop-1-yn-1-yl)isoindoline-1,3-dione
CAS No.2493430-94-5

Synthetic Route by SureRoute

1. ACAVFX797 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPTZY476 route compound structure diagram
    ACPTZY47663478-76-2 In Stock
  2. Plus
  3. ACHFYP174 route compound structure diagram
    ACHFYP1742509137-01-1 In Stock
  4. Then
  5. ACAVFX797 route product structure diagram
    ACAVFX7972493430-94-5
Inquiry

2. ACAVFX797 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPTZY476 route compound structure diagram
    ACPTZY47663478-76-2 In Stock
  2. Plus
  3. ACNYZE284 route compound structure diagram
    ACNYZE28426166-92-7 In Stock
  4. Then
  5. ACAVFX797 route product structure diagram
    ACAVFX7972493430-94-5
Inquiry

Comments (0)